RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
DE NICOLò A
Collezione ASL Città di Torino
Items : 105
UHPLC-MS/MS method for the simultaneous quantification of five calcium channel antagonists' drugs in human plasma. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2025 Mar;184:117873. doi: 10.1016/j.biopha.2025.117873. Epub 2025 Feb 5.
2025
ASL Città di Torino
Rabbia F; Cantù M; De Rosa FG; Fasano C; Ponsa L; Pappaccogli M; Menegatti G; Antonucci M; Manca A; Cusato J; De Nicolò A; Billi M; Palermiti A; Veglio F; D'Avolio A;
Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug Interactions. in Pharmaceutics / Pharmaceutics. 2025 Feb 14;17(2):250. doi: 10.3390/pharmaceutics17020250.
2025
ASL Città di Torino
Billi M; Soloperto S; Bonora S; D'Avolio A; De Nicolò A;
Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano
Boglione L; D'Avolio A; De Nicolò A; Lupia T; Stroffolini G; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Cusato J;
Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.
2024
ASL Città di Torino
D'Avolio A; Marinaro L; Alladio F; Ponzetta L; Cat Genova E; Quaranta M; Stroffolini G; Venuti F; de Nicolò A; Gaviraghi A; Calcagno A;
Pharmacokinetics of tecovirimat in subjects with Mpox. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 De
2024
ASL Città di Torino
Tempestilli M; Mondi A; D'Avolio A; Forini O; Pinnetti C; Mazzotta V; Gagliardini R; Beccacece A; De Nicolò A; Faccendini P; Cimini E; Maggi F; Girardi E; Nicastri E; Boffito M; Vaia F; Antinori A;
Development and Validation of a UHPLC-MS/MS Method for the Simultaneous Quantification of Candesartan and Bisoprolol Together with Other 16 Antihypertensive Drugs in Plasma Samples. in Journal of medicinal chemistry / J Med Chem. 2024 Dec 26;67(24):22124-22133. doi: 10.1021/acs.jmedchem.4c02045. Epub 2024 Dec 4.
2024
ASL Città di Torino
Veglio F; Rabbia F; De Rosa FG; Fasano C; Ponsa L; Pappaccogli M; Carta A; Cusato J; Billi M; Mula J; Antonucci M; Manca A; De Nicolò A; Palermiti A; D'Avolio A;
Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy. in Pharmaceutics / Pharmaceutics. 2023 Sep 19;15(9):2347. doi: 10.3390/pharmaceutics15092347.
2023
ASL Città di Torino
Manca A; Palermiti A; Mula J; Cusato J; Maiese D; Simiele M; De Nicolò A; D'Avolio A;
A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human Tissues. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2023 Jun 19;16(6):903. doi: 10.3390/ph16060903.
2023
ASL Città di Torino
Manca A; De Nicolò A; De Vivo ED; Ferrara M; Oh S; Khalili S; Higgins N; Deiss RG; Bonora S; Cusato J; Palermiti A; Mula J; Gianella S; D'Avolio A;
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214.
2023
ASL Città di Torino
Bonora S; Cinnirella G; D'Avolio A; Marchiaro C; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Longo BM; Stroffolini G; De Nicolò A; Gaviraghi A; Venuti F; Calcagno A;
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Jul;163:114790. doi: 10.1016/j.biopha.2023.114790. Epub 2023 Apr 29.
2023
ASL Città di Torino
AOU San Luigi di Orbassano
De Nicolò A; De Rosa FG; Di Perri G; Simiele M; Cusato J; Maiese D; Palermiti A; Manca A; Chiara F; Mula J; D'Avolio A;
A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients. in Irish journal of medical science / Ir J Med Sci. 2023 Feb;192(1):423-430. doi: 10.1007/s11845-022-02952-9. Epub 2022 Feb 19.
2023
ASL Città di Torino
di Masi A; Cusato J; Koncan R; Di Bella S; Zerbato V; Segat L; Sanson G; De Nicolò A; Palermo A; Caironi P; D'Agaro P; Luzzati R; D'Avolio A;
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2023 Dec 1;78(12):3003-3004. doi: 10.1093/jac/dkad299.
2023
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Mangiapia M; Cusato J; Mornese Pinna S; Scabini S; De Nicolò A; Corcione S; Vita D; De Rosa FG;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Caviglia GP; Mornese Pinna S; Ciancio A; Troshina G; Smedile A; Antonucci M; Avataneo V; Palermiti A; Mula J; Manca A; Cariti G; Cantù M; Saracco GM; Di Perri G; D'Avolio A;
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.
2022
ASL Città di Torino
Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic Study. in Molecules (Basel, Switzerland) / Molecules. 2022 Feb 3;27(3):1042. doi: 10.3390/molecules27031042.
2022
ASL Città di Torino
Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.
2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; Di Perri G; D'Avolio A; Mula J; Lupia T; Vita D; De Benedetto I; Scabini S; De Nicolò A; Montrucchio G; Mornese Pinna S; Corcione S;
A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
De Filippis G; Vischia F; De Cori D; Cusato J; D'Avolio A; De Nicolò A; Imperiale D; Maiese D; Mula J; Zeaiter S; Palermiti A; Manca A; Chiara F;
Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy. in Journal of preventive medicine and hygiene / J Prev Med Hyg. 2022 Oct 27;63(3):E420-E423. doi: 10.15167/2421-4248/jpmh2022.63.3.2137. eCollection
2022
ASL Città di Torino
Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study. in Therapie / Therapie. 2021 Sep-Oct;76(5):409-414. doi: 10.1016/j.therap.2020.10.003. Epub 2020 Oct 23.
2021
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; Di Perri G; Stella M; D'Avolio A; Corgiat Loia R; Romeo MR; Pensa A; Lupia T; Segala FV; Corcione S; De Nicolò A;
Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino
Cusato J; Mula J; Palermiti A; Manca A; Antonucci M; Avataneo V; De Vivo ED; Ianniello A; Calcagno A; Di Perri G; De Nicolò A; D'Avolio A;
Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2021 Nov 12;76(12):3320-3322. doi: 10.1093/jac/dkab319.
2021
ASL Città di Torino
Tempestilli M; D'Avolio A; De Nicolò A; Agrati C; Antinori A; Cicalini S;
Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.
2021
ASL Città di Torino
Palermiti A; Cafaro A; Barco S; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino
Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;
Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients. in Scientific reports / Sci Rep. 2021 Jan 11;11(1):443. doi: 10.1038/s41598-020-79574-7.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Romagnoli R; Canaparo R; Tandoi F; Catalano S; Serpe L; Dell'Olio D; D'Avolio A; Antonucci M; Pizzol A; De Nicolò A; Pinon M; Calvo PL;
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino
Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino
Corcione S; De Nicolò A; Montrucchio G; Scabini S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring. in Frontiers in pharmacology / Front Pharmacol. 2022 Jan 5;12:755184. doi: 10.3389/fphar.2021.755184. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Veglio F; D'Avolio A; De Rosa FG; Cusato J; Pappaccogli M; Palermiti A; De Nicolò A; Rabbia F; Fanelli E; Avataneo V;
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. in Nutrients / Nutrients. 2020 May 9;12(5):1359. doi: 10.3390/nu12051359.
2020
ASL Città di Torino
D'Avolio A; Avataneo V; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M;
Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Romeo M; Di Perri G; Stella M; De Rosa FG; Loia RC; Pensa A; Segala FV; De Nicolò A; Fatiguso G; Corcione S; D'Avolio A;
Data on the stability of darunavir/cobicistat suspension after tablet manipulation. in Data in brief / Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun.
2020
ASL Città di Torino
Minghetti P; Tomasello C; Maximova N; Cilurzo F; D'Avolio A; Musazzi UM; De Nicolò A; Zanon D; Manca A;
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
AOU San Luigi di Orbassano
Antonucci M; D'Avolio A; Manca A; Avataneo V; Cusato J; Allegra S; De Francia S; De Nicolò A;
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152.
2020
ASL Città di Torino
Avataneo V; de Nicolò A; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;
Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis. in Journal of infection and public health / J Infect Public Health. 2020 Feb;13(2):315-316. doi: 10.1016/j.jiph.2019.12.005. Epub 2020 Jan 15.
2020
ASL Città di Torino
De Benedetto I; Boglione L; Salvador E; Lupia T; De Nicolò A; Di Perri G; Lipani F; Lucchini AM;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients. in Data in brief / Data Brief. 2020 Dec;33:106445. doi: 10.1016/j.dib.2020.106445. Epub 2020 Oct 23.
2020
ASL Città di Torino
Minghetti P; Tomasello C; Clementi E; Maximova N; Cilurzo F; D'Avolio A; De Nicolò A; Manca A; Zanon D; Musazzi UM;
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;
LC-MS application for therapeutic drug monitoring in alternative matrices. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29.
2019
ASL Città di Torino
Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis. in Neurocritical care / Neurocrit Care. 2019 Aug;31(1):116-124. doi: 10.1007/s12028-018-0657-y.
2019
ASL Città di Torino
Piva S; Di Paolo A; Galeotti L; Ceccherini F; Cordoni F; Signorini L; Togni T; De Nicolò A; Rasulo FA; Fagoni N; Latronico N; D'Avolio A;
Flecainide plasma level modifications during ledipasvir/sofosbuvir coadministration in two patients affected by chronic hepatitis C. in Antiviral therapy / Antivir Ther. 2019;24(7):553-555. doi: 10.3851/IMP3328.
2019
ASL Città di Torino
Boglione L; De Nicolò A; Di Perri G; D'Avolio A;
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A; Avataneo V; De Nicolò A; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Fatiguso G; Allegra S; Favata F; Mulatero P; Veglio F; Di Perri G; D'Avolio A;
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F; Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F;
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;
Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; D'Avolio A; Carcieri C; Carcieri C; Tomasello C; Simiele M; De Nicolò A; Avataneo V; Canzoneri L; Cusato J; Di Perri G; D'Avolio A;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino
Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. in Antiviral therapy / Antivir Ther. 2018;23(4):373-377. doi: 10.3851/IMP3207.
2018
ASL Città di Torino
De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino
El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino
Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;
Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient. in Journal of clinical pharmacy and therapeutics / J Clin Pharm Ther. 2017 Oct;42(5):621-623. doi: 10.1111/jcpt.12546. Epub 2017 May 4.
2017
ASL Città di Torino
Taibi C; Tempestilli M; D'Avolio A; Garbuglia AR; De Nicolò A; Montalbano M; D'Offizi G;
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino
Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:223-230. doi: 10.1016/j.jpba.2017.02.002. Epub 2017 Feb 3.
2017
ASL Città di Torino
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients. in Journal of mass spectrometry : JMS / J Mass Spectrom. 2017 Mar;52(3):187-195. doi: 10.1002/jms.3909.
2017
ASL Città di Torino
AOU Città della Salute di Torino
Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino
Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. in Bioanalysis / Bioanalysis. 2017 Jul;9(14):1093-1105. doi: 10.4155/bio-2017-0059. Epub 2017 Jul 24.
2017
ASL Città di Torino
De Nicolò A; Cantù M; D'Avolio A;
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino
Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino
Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V; De Nicolò A; Avataneo V; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A;
UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Sep 10;129:535-541. doi: 10.1016/j.jpba.2016.07.049. Epub 2016 Aug 1.
2016
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Veglio F; Mulatero P; Perlo E; Tomasello C; Cusato J; Bonifacio G; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;
Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis B. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Sep;48(3):324-7. doi: 10.1016/j.ijantimicag.2016.05.016. Epub 2016 Jul
2016
ASL Città di Torino
Boglione L; De Nicolò A; Cusato J; Bonifacio G; Cariti G; Di Perri G; D'Avolio A;
Antihypertensive Bridge Therapy by Continuous Drug Infusion With an Elastomeric Pump in Device-Resistant Hypertension. in Hypertension (Dallas, Tex. : 1979) / Hypertension. 2016 Mar;67(3):e3-4. doi: 10.1161/HYPERTENSIONAHA.115.06978. Epub 2016 Jan 18.
2016
ASL Città di Torino
AOU Città della Salute di Torino
Veglio F; Taddei S; Mulatero P; Bruno RM; Berra E; De Nicolò A; Fulcheri C; Bernini G; D'Avolio A; Rabbia F;
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jun 5;125:369-75. doi: 10.1016/j.jpba.2016.04.031. Epub 2016 Apr 20.
2016
ASL Città di Torino
Ariaudo A; Favata F; De Nicolò A; Simiele M; Paglietti L; Boglione L; Cardellino CS; Carcieri C; Di Perri G; D'Avolio A;
Pharmacogenetics of ribavirin-induced anemia in HCV patients. in Pharmacogenomics / Pharmacogenomics. 2016 Jun;17(8):925-41. doi: 10.2217/pgs.16.22. Epub 2016 Jun 1.
2016
ASL Città di Torino
D'Avolio A; Cusato J; De Nicolò A; Allegra S; Di Perri G;
Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2016 Jun;26(6):307-10. doi: 10.1097/FPC.0000000000000223.
2016
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. in International journal of pharmaceutical compounding / Int J Pharm Compd. 2016 Jul-Aug;20(4):343-346.
2016
ASL Città di Torino
AOU Città della Salute di Torino
De Perri G; De Nicolò A; Fulcheri C; Baietto L; Rabbia F; Veglio F; Leggieri A; D'Avolio A; Tomasello C;
UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino
Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A; De Nicolò A; Bonifacio G; Boglione L; Cusato J; Pensi D; Tomasello C; Di Perri G; D'Avolio A;
A Possible Role of Therapeutic Drug Monitoring in Virological Breakthrough during Simeprevir and PEG-IFN Treatment in HCV-4. in Intervirology / Intervirology. 2016;59(5-6):283-284. doi: 10.1159/000477809. Epub 2017 Jun 22.
2016
ASL Città di Torino
Boglione L; Ruggiero T; De Nicolò A; D'Avolio A; Di Perri G;
A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino
Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:127-32. doi: 10.1016/j.jpba.2015.05.016. Epub 2015 May 22.
2015
ASL Città di Torino
De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A;
UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Nov 10;115:443-9. doi: 10.1016/j.jpba.2015.08.004. Epub 2015 Aug 4.
2015
ASL Città di Torino
De Nicolò A; Abdi AM; Boglione L; Baiett L; Allegra S; Di Perri G; D'Avolio A;
An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Mar 25;107:512-7. doi: 10.1016/j.jpba.2015.01.054. Epub 2015 Feb 7.
2015
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Brunati A; Nonnato A; Calvo PL; Pinon M; De Nicolò A; Pensi D; D'Avolio A;
Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. in Journal of viral hepatitis / J Viral Hepat. 2015 Mar;22(3):318-27. doi: 10.1111/jvh.12288. Epub 2014 Jul 24.
2015
ASL Città di Torino
Boglione L; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 Jun;45(6):657-61. doi: 10.1016/j.ijantimicag.2015.01.019. Epub 2015 Ma
2015
ASL Città di Torino
Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Abdi AM; Cariti G; Di Perri G; D'Avolio A;
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:63-9. doi: 10.1016/j.biopha.2014.11.007. Epub 2014 Nov 15.
2015
ASL Città di Torino
Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Cariti G; Ciancio A; Smedile A; Strona S; Troshina G; Rizzetto M; Di Perri G; D'Avolio A;
Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:47-55. doi: 10.1016/j.biopha.2014.10.030. Epub 2014 Nov 6.
2015
ASL Città di Torino
Allegra S; Cusato J; De Nicolò A; Boglione L; Gatto A; Cariti G; Di Perri G; D'Avolio A;
Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2015 Feb;21(2):205.e1-3. doi: 10.1016/j.cmi.2014.07.009. Epub 2014 Oct 29.
2015
ASL Città di Torino
Boglione L; De Nicolò A; Cardellino CS; Ruggiero T; Ghisetti V; Cariti G; Di Perri G; D'Avolio A;
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2015 Apr;25(4):164-72. doi: 10.1097/FPC.0000000000000123.
2015
ASL Città di Torino
Cusato J; Allegra S; Boglione L; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Apr;70(4):1155-60. doi: 10.1093/jac/dku519. Epub 2015 Jan 11.
2015
ASL Città di Torino
Milazzo L; Peri AM; Mazzali C; Magni C; Calvi E; De Nicolò A; Clementi E; Cheli S; D'Avolio A; Antinori S; Falvella FS;
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir. in Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques / J Pharm Pharm Sci. 2015;18(2):171-6. doi: 10.18433/j3dk6t.
2015
ASL Città di Torino
Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Mohamed Abdi A; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. in Antiviral therapy / Antivir Ther. 2015;20(3):335-41. doi: 10.3851/IMP2853. Epub 2014 Oct 3.
2015
ASL Città di Torino
Cusato J; Allegra S; Boglione L; De Nicolò A; Baietto L; Cariti G; Di Perri G; D'Avolio A;
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. in Antiviral research / Antiviral Res. 2014 Sep;109:7-14. doi: 10.1016/j.antiviral.2014.06.005. Epub 2014 Jun 20.
2014
ASL Città di Torino
De Nicolò A; Boglione L; Ciancio A; Cusato J; Strona S; Cardellino CS; Abdi AM; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G; D'Avolio A;
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Sep;98:271-8. doi: 10.1016/j.jpba.2014.05.040. Epub 2014 Jun 7.
2014
ASL Città di Torino
De Nicolò A; Agnesod D; Simiele M; Riganò D; Adriani A; Canaparo R; Astegiano M; Rizzetto M; Di Perri G; D'Avolio A;
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E. in Journal of medical virology / J Med Virol. 2014 Nov;86(11):1845-50. doi: 10.1002/jmv.24038. Epub 2014 Aug 8.
2014
ASL Città di Torino
Boglione L; Cardellino CS; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Mar;90:119-26. doi: 10.1016/j.jpba.2013.11.027. Epub 2013 Dec 1.
2014
ASL Città di Torino
Agnesod D; De Nicolò A; Simiele M; Mohamed Abdi A; Boglione L; Di Perri G; D'Avolio A;
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. in Antiviral research / Antiviral Res. 2014 Jun;106:105-10. doi: 10.1016/j.antiviral.2014.03.016. Epub 2014 Apr 12.
2014
ASL Città di Torino
Boglione L; Cusato J; De Nicolò A; Cariti G; Allegra S; Ghisetti V; Di Perri G; D'Avolio A;
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino
De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;
Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools. in Journal of hepatology / J Hepatol. 2014 Jul;61(1):178-9. doi: 10.1016/j.jhep.2014.02.035. Epub 2014 Mar 21.
2014
ASL Città di Torino
Boglione L; De Nicolò A; Di Perri G; D'Avolio A;
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir. in Journal of viral hepatitis / J Viral Hepat. 2014 Apr;21(4):260-3. doi: 10.1111/jvh.12170. Epub 2013 Sep 2.
2014
ASL Città di Torino
Boglione L; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. in Antiviral research / Antiviral Res. 2013 Oct;100(1):114-9. doi: 10.1016/j.antiviral.2013.07.021. Epub 2013 Aug 8.
2013
ASL Città di Torino
D'Avolio A; De Nicolò A; Cusato J; Ciancio A; Boglione L; Strona S; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G;
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2013 May 5;78-79:217-23. doi: 10.1016/j.jpba.2013.02.025. Epub 2013 Feb 27.
2013
ASL Città di Torino
D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G;
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. in Journal of viral hepatitis / J Viral Hepat. 2013 Apr;20(4):e11-9. doi: 10.1111/jvh.12018. Epub 2013 Feb 18.
2013
ASL Città di Torino
Boglione L; D'Avolio A; Cariti G; Milia MG; Simiele M; De Nicolò A; Ghisetti V; Di Perri G;
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino
D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;